Terminology Service < Semantic Lookup Platform

All terms in CLO

Label	Id	Description
uterine cancer	DOID_363
GM19707 cell	CLO_0026915	[ INTERNATIONAL HAPMAP PROJECT - PLATE OF AFRICAN ANCESTRY FROM THE SW USA INTERNATIONAL HAPMAP PROJECT - AFRICAN ANCESTRY FROM THE SW USA]
ND09212 cell	CLO_0014946	[ AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE UNITED STATES ALS PANEL CAUCASIAN FROM THE US]
immortal pulmonary vein-derived cell line cell	CLO_0000306
F18 AF1 cell	CLO_0002969	[disease: hybridoma]
F1792 cell	CLO_0002968
immortal buttock-derived fibroblast cell line cell	CLO_0000307
NCBITaxon_Union_0000023	NCBITaxon_Union_0000023
immortal tonsil-derived cell line cell	CLO_0000308
immortal umbilicus-derived fibroblast cell line cell	CLO_0000309
conduct disorder	DOID_12995
monovalent inorganic anion	CHEBI_79389
inorganic anion	CHEBI_24834
divalent inorganic anion	CHEBI_79388
immunoglobulin complex	GO_0019814	[Note that an immunoglobulin complex has the function of antigen binding if a suitable antigen is available.]
protein-containing complex	GO_0032991	[A protein complex in this context is meant as a stable set of interacting proteins which can be co-purified by an acceptable method, and where the complex has been shown to exist as an isolated, functional unit in vivo. Acceptable experimental methods include stringent protein purification followed by detection of protein interaction. The following methods should be considered non-acceptable: simple immunoprecipitation, pull-down experiments from cell extracts without further purification, colocalization and 2-hybrid screening. Interactions that should not be captured as protein complexes include: 1) enzyme/substrate, receptor/ligand or any similar transient interactions, unless these are a critical part of the complex assembly or are required e.g. for the receptor to be functional; 2) proteins associated in a pull-down/co-immunoprecipitation assay with no functional link or any evidence that this is a defined biological entity rather than a loose-affinity complex; 3) any complex where the only evidence is based on genetic interaction data; 4) partial complexes, where some subunits (e.g. transmembrane ones) cannot be expressed as recombinant proteins and are excluded from experiments (in this case, independent evidence is necessary to find out the composition of the full complex, if known). Interactions that may be captured as protein complexes include: 1) enzyme/substrate or receptor/ligand if the complex can only assemble and become functional in the presence of both classes of subunits; 2) complexes where one of the members has not been shown to be physically linked to the other(s), but is a homologue of, and has the same functionality as, a protein that has been experimentally demonstrated to form a complex with the other member(s); 3) complexes whose existence is accepted based on localization and pharmacological studies, but for which experimental evidence is not yet available for the complex as a whole.]
B cell receptor complex	GO_0019815	[Note that an immunoglobulin complex has the function of antigen binding if a suitable antigen is available.]
plasma membrane signaling receptor complex	GO_0098802	[Note that this term is in the subset of terms that should not be used for direct gene product annotation. Instead, select a child term or, if no appropriate child term exists, please request a new term. Direct annotations to this term may be amended during annotation QC.]
Protostomia	NCBITaxon_33317
Bilateria	NCBITaxon_33213